Prior to founding Amalgam Rx, Mr. Sysko was the Co-Founder, CEO, and Chairman of WellDoc. The company helped pioneer the mobile health (“mHealth”) industry with one of the earliest FDA cleared, clinically-validated (through multiple randomized controlled trials), prescribed and reimbursed digital health products. The American Diabetes Association has listed WellDoc’s product, BlueStar, as the first and only Mobile Prescription Therapy. WellDoc has been recognized by Forbes as “One of America’s Most Promising Companies,” by the NASDAQ as “One of the Next Great Consumer Brands,” and by SmartCEO as a “Future 50 Fastest Growing Company.” Mr. Sysko has extensive background in helping to launch and develop start-up companies.
He was previously the senior vice president and director of marketing and business development for The Credo Group, one of the leading direct-to-consumer marketers of life and health insurance products on the Web. Prior to The Credo Group, he served in management positions within financial services companies such as Chase, Bank of America, and Conseco.
